FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients |
FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients
Food and Drug Administration Commissioner Marty Makary said in September he was changing leucovorin’s label because it could help “hundreds of thousands” of children with the neurological condition.
FDA Commissioner Marty Makary speaks alongside President Donald........